Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
Titel:
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
Auteur:
Roux, C. Hofbauer, L.C. Ho, P.R. Wark, J.D. Zillikens, M.C. Fahrleitner-Pammer, A. Hawkins, F. Micaelo, M. Minisola, S. Papaioannou, N. Stone, M. Ferreira, I. Siddhanti, S. Wagman, R.B. Brown, J.P.